DVT Prophylaxis Compression Stockings: Grading and Selection Guide

“Compression stockings” covers two genuinely different product categories, and confusing them is where selection mistakes happen. Retail graduated-compression socks marketed for travel or all-day standing sit in the 8–15 mmHg range and are not a DVT-prophylaxis device. Hospital-grade graduated compression stockings (GCS) and anti-embolism stockings (AES, commonly called TED hose) are medical devices with a specific pressure grade, a specific patient population, and a specific evidence base — and the two are not interchangeable with each other either. This guide covers the mmHg grading system, the actual clinical decision for mechanical VTE prophylaxis, and what changes when you’re stocking a unit rather than fitting one patient.

Scope. Written for nurse educators, materials/supply-chain staff and patient-safety or quality-improvement leads who select, stock, or write policy around compression garments for VTE prevention — not clinical guidance for an individual patient’s care plan, which stays with the treating clinician and the institution’s own VTE-prophylaxis protocol. Grading numbers and class definitions below follow the widely used compression-garment classification conventions; always confirm the specific pressure rating printed on a given manufacturer’s product and package insert rather than assuming a class label alone is precise enough for reordering.

The mmHg grading system: what the numbers mean

Graduated compression is engineered to be tightest at the ankle and progressively looser moving up the leg, which is what distinguishes it from a uniform-pressure elastic bandage or a plain support sock. The pressure is specified in millimeters of mercury (mmHg) measured at the ankle (the B1 point in compression-garment testing standards), and medical compression garments are conventionally grouped into classes:

• Mild (15–20 mmHg): minor edema, tired/aching legs, early varicose veins, long-haul travel. Not a DVT-prophylaxis grade on its own.
• Moderate (20–30 mmHg): the most common grade for symptomatic chronic venous insufficiency, post-sclerotherapy care, and moderate edema. Often the grade used for ambulatory patients at elevated VTE risk who are able to walk and tolerate a stronger garment.
• Firm (30–40 mmHg): significant venous insufficiency, venous ulcer management, lymphedema, and some post-thrombotic-syndrome protocols. Requires a prescription/fitting in most jurisdictions and closer monitoring for skin tolerance.
• Extra-firm (40–50 mmHg and above): severe lymphedema and select vascular indications, rarely a standard-stock item outside a vascular or lymphedema clinic.

Two things matter more than memorizing the bands. First, national/regional compression-classification systems (the older German RAL system, the French system, and the more recent harmonized standards) don’t all draw the class boundaries at exactly the same mmHg values — when a product is labeled “Class II,” confirm which system the manufacturer is using rather than assuming it maps to “20–30 mmHg” automatically. Second, in-hospital anti-embolism stockings are their own category, not just “the mild end of the same scale,” which is the next distinction that actually drives a purchasing decision.

Anti-embolism stockings vs. ambulatory graduated compression stockings

These two device classes are both called “compression stockings” colloquially, and both appear in VTE-prophylaxis literature, but they are built and validated for different patients:

• Anti-embolism stockings (AES / TED hose): designed for non-ambulatory or minimally-ambulatory patients — the classic post-operative or bedbound-medical-patient use case. Pressure is typically graded lower than therapeutic GCS (commonly in a ~15–18 mmHg ankle-gradient range across manufacturers, always confirm the specific product’s rating) because the mechanism relies on maintaining venous return in a limb that isn’t being actively used by calf-muscle-pump action from walking. Sized by calf/thigh circumference and length (knee-length, thigh-length, or waist-length/pantyhose-style), not by shoe size the way retail compression socks often are.
• Ambulatory graduated compression stockings: higher-pressure garments intended for a patient who is up and moving, where the calf-muscle pump is doing real work and the stocking is managing venous insufficiency or post-thrombotic risk rather than substituting for muscle-pump action. These are a chronic-venous-disease and outpatient-VTE-risk-management product, not primarily a perioperative/bedbound one.

The practical selection failure mode is stocking one grade and length and using it for both populations. A firm ambulatory-grade stocking put on an immobile post-op patient can be harder to don correctly, more prone to rolling/tourniqueting at the top edge if it migrates, and doesn’t match what the unit’s VTE-prophylaxis order set actually specifies. A unit that admits both surgical/immobile patients and ambulatory patients with chronic venous disease or post-thrombotic syndrome generally needs both categories on formulary, not one “compression stocking” SKU covering both.

Where mechanical prophylaxis fits the VTE-prevention decision

Hospital-acquired VTE (DVT and pulmonary embolism) is a tracked hospital-acquired condition and a patient-safety-indicator target — see CASRAI’s HAC Reduction Program guide and AHRQ Patient Safety Indicators guide for how VTE-related measures feed into the measure set hospitals are scored and penalized against. The prophylaxis decision itself runs through three questions, in this order:

1. Does this patient need VTE prophylaxis at all, and at what risk tier? Structured risk-assessment tools (the Caprini score and Padua score are the most widely used) stratify surgical and medical inpatients respectively into risk tiers that drive the prophylaxis decision — this mirrors the same risk-tiered-intervention pattern CASRAI covers in the fall-prevention program design guide: a screening score only does its job if the tier it produces actually maps to a defined intervention set in the order set or protocol.
2. Is pharmacologic prophylaxis (typically low-molecular-weight or unfractionated heparin, or a direct oral anticoagulant depending on indication) appropriate, or contraindicated? Active bleeding, recent major surgery with high bleeding risk, and certain platelet counts are the classic reasons a patient lands on mechanical-only prophylaxis instead.
3. If mechanical prophylaxis is indicated — either as the sole modality or as an adjunct to pharmacologic prophylaxis — is that graduated compression stockings, intermittent pneumatic compression (IPC), or both? Current guidance in most contemporary VTE-prevention protocols leans more heavily on IPC than on GCS alone for many inpatient populations; GCS is more consistently supported as an adjunct in specific surgical contexts and for chronic venous disease management than as a stand-alone mechanical prophylaxis strategy across general medical inpatients. This shift followed evidence — most visibly the CLOTS trial program in immobile stroke patients — that thigh-length GCS did not demonstrate a clear DVT-prevention benefit in that population and was associated with a meaningfully higher rate of skin complications (breaks, blisters, ulceration) than no stockings. Treat the exact effect sizes as something to confirm against the current version of your institution’s adopted VTE-prophylaxis guideline rather than cited here as a fixed number — the directional finding (don’t assume GCS is risk-free or automatically effective) is the operationally important part for a purchasing/protocol decision.

The practical upshot for anyone stocking or writing policy around these products: mechanical prophylaxis selection is a clinical-protocol decision, not just a product-catalog decision, and “we have compression stockings on formulary” is not the same statement as “our GCS use is aligned with current guidance for the populations we’re using it on.”

Contraindications and fit — where a wrong-size or wrong-population stocking causes harm

Compression garments are not a benign default. The recognized contraindications and cautions that should sit in any unit’s screening step before applying either AES or ambulatory GCS include:

• Known or suspected peripheral arterial disease (compression on a limb with compromised arterial supply can worsen ischemia) — an ankle-brachial index check is the standard screen where PAD is suspected.
• Severe peripheral neuropathy, where the patient can’t reliably report pain or pressure injury developing under the garment.
• Recent skin graft, dermatitis, gangrene, or open wound at the application site.
• Massive leg edema or an unusual limb shape/size that the stocking’s sizing chart doesn’t fit — forcing an undersized stocking onto a limb it wasn’t sized for is a common source of a tourniquet effect at the proximal edge, which can itself impair rather than assist venous return.
• Congestive heart failure severe enough that redistributing venous volume centrally via compression is a clinical concern — this is a judgment call for the treating clinician, not a stocking-selection rule, but it’s a reason fit-and-apply staff should not treat “just put the stockings on” as a task independent of the clinical picture.

Correct sizing is measured, not eyeballed: calf circumference at its widest point and leg length are the two measurements that actually determine size on most manufacturers’ charts, and a stocking selected by shoe size or general build guesses wrong often enough to matter. Re-measurement is also a real practice point — a patient’s leg circumference changes with the same edema or fluid shifts that made prophylaxis necessary in the first place, so a stocking fitted on admission can be the wrong size a few days later.

Selecting and stocking grades for a unit

Translating the clinical picture above into a formulary decision, most medical/surgical units carrying compression prophylaxis products need to stock, at minimum:

• Anti-embolism stockings in both knee-length and thigh-length, across the unit’s typical size range (most manufacturers publish a sizing chart by calf circumference and length — stock enough size breakpoints that staff aren’t rounding a patient into the wrong size because the correct one isn’t in the supply closet).
• A moderate-grade (20–30 mmHg) ambulatory GCS option for patients transitioning to mobility or managed for chronic venous disease/post-thrombotic syndrome, distinct from the AES line above.
• A documented fit-check and reassessment step in the nursing workflow — skin checks under the stocking on a defined schedule, not just at initial application, given the skin-complication signal noted above.
• IPC sleeves/compressors as the accompanying mechanical-prophylaxis option, since most current protocols use GCS and IPC as distinct tools for different situations rather than one substituting cleanly for the other.

Sourcing note: LAC (lac.us), CASRAI’s sister medical-supply company, stocks compression and anti-embolism stockings across common size and length breakpoints; it’s a reasonable starting point for pricing out a unit-level restock once your protocol has defined the grades and lengths you actually need — confirm the specific mmHg rating on the product page against what your institution’s VTE-prophylaxis policy calls for before ordering, since not every listing states a precise class per the harmonized system above.

Frequently asked questions

What mmHg is used for DVT prophylaxis specifically?

There isn’t one universal number. In-hospital anti-embolism stockings for non-ambulatory patients are typically graded lower (commonly in the ~15–18 mmHg range, product-dependent) than the moderate 20–30 mmHg grade often used for ambulatory patients managed for venous insufficiency or post-thrombotic risk. Always confirm the specific product’s rated pressure and your institution’s protocol rather than assuming a single figure applies across populations.

Are graduated compression stockings and anti-embolism stockings the same thing?

No. They’re related device categories that are frequently used interchangeably in casual conversation but are validated and sized for different patients — anti-embolism stockings for non-ambulatory/perioperative use, ambulatory graduated compression stockings for patients who are up and walking. See the comparison above.

Do compression stockings replace pharmacologic VTE prophylaxis?

Not as a general rule. Mechanical prophylaxis (GCS and/or IPC) is most often used as an adjunct to pharmacologic prophylaxis, or as the primary strategy specifically when pharmacologic prophylaxis is contraindicated (active bleeding risk, for example). The choice sits with the treating clinician and the institution’s VTE-prophylaxis protocol, driven by a structured risk assessment such as the Caprini or Padua score.

Why did some hospitals move away from routine graduated compression stockings?

Evidence in specific populations — most visibly immobile stroke patients in the CLOTS trial program — did not show a clear DVT-prevention benefit from thigh-length GCS and found a meaningfully higher rate of skin complications compared with no stockings, which shifted guidance in that population toward IPC instead. That finding is population-specific; it does not mean GCS has no role in VTE prevention broadly, particularly in chronic venous disease management and specific surgical contexts. Confirm current guidance for your specific patient population before changing a protocol.